Vivos (RDGL) EBT Margin (QoQ) (2011 - 2025)
Vivos (RDGL) EBT Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | Vivos | 27.62 Mn | 26.06 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | -118,283.00 |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | -397,898.00 |
| Sep 30, 2024 | -1.28 Mn |
| Jun 30, 2024 | 868,266.00 |
| Sep 30, 2023 | 434,659.00 |
| Jun 30, 2023 | -974,638.00 |
| Mar 31, 2023 | 671,924.00 |
| Dec 31, 2022 | -659,533.00 |
| Sep 30, 2022 | 323,782.00 |
| Jun 30, 2022 | -211,648.00 |
| Dec 31, 2019 | -2.52 Mn |
| Sep 30, 2016 | 9.93 Mn |
| Jun 30, 2016 | 4.00 Mn |
| Jun 30, 2014 | -458,465.00 |
| Mar 31, 2013 | 350,969.00 |
| Dec 31, 2012 | -232,966.00 |
| Sep 30, 2012 | 0.00 |